Ticker

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH - Get Free Report) shares saw an uptick in trading volume on Monday. 145,914 shares changed hands during mid-day trading, an increase of 46% from the previous session's volume of 100,158 shares. The stock last traded at $66.16 and had previously closed at $66.09. SPDR S&P Pharmaceuticals ETF Stock Performance

Integrated Wealth Concepts LLC purchased a new position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the undefined quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 48,874 shares of the company's stock, valued at approximately $3,350,000. Integrated Wealth Concepts LLC owned approximately

iShares Global Healthcare ETF provides broad sector coverage with a higher dividend yield than State Street SPDR S&P Pharmaceuticals ETF. State Street SPDR S&P Pharmaceuticals ETF has delivered stronger total returns over the last year but experiences significantly higher maximum drawdowns.

Vanguard's broader healthcare portfolio charges less and yields more, but State Street's pharma-focused fund has delivered stronger recent gains despite higher volatility.

FHLC captures the whole healthcare opportunity at rock-bottom cost. XPH narrows the bet to pharmaceuticals and charges significantly more for it.